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In 2012, a new highly pathogenic coronavirus was isolated from a 60-year old man in Saudi Arabia, who died of progressive respiratory and renal failure [8] .
This novel coronavirus later was termed as Middle East respiratory syndrome coronavirus (MERS-CoV) according to the
Coronavirus Study Group of the International
Committee on Taxonomy of Viruses (ICTV) [9] . The genomic sequence analysis reveals that MERS-CoV is phylogenetically related to the BtCoV-HKU4 and BtCoV-HKU5, and thus belongs to lineage C of the genus betacoronavirus. MERS-CoV infection leads to fever, cough, shortness of breath and even severe pneumonia. Gastrointestinal symp--toms, disseminated intravascular coagula--tion and kidney failure have also been reported [10] . The emergence of MERS-CoV renews the interest in HCoVs and highlights the HCoVs as an important highly pathogenic agent for human.
MERS-CoV transmission
As MERS-CoV shows high similarity to the bat coronaviurses, and the MERS--CoV-related viruses have been detected in bats, MERS-CoV is considered as a zoonosis that originates from bats [11] . [12] . In addition, the MERS-CoV genomic sequences from a sick dromedary camel were identical to the sequences of virus from a patient who had close contact with the sick camel [13] . Collectively, these findings provide the evidence for camel- 
Animal models for MERS-CoV
The availability of animal models is essential for clarification of viral patho--genesis and for development of preventive and therapeutic agents against virus infection. As a specific functional receptor, DPP4 was used by MERS-CoV to initiate virus infection [14] . [15] .
Additionally, the common marmosets were also available to be infected by MERS-CoV via combined intratracheal, intranasal, oral and ocular routes [16] . However, it is not proper to use these animal models since the primates are expensive with limited availability.
The small and economical models were also developed in different laboratories. Mice were susceptible to MERS-CoV after infec--tion with a DPP4-expressing adenovirus, which was used to express the DPP4 receptor in the lung cells [17] . Recently, a stable model fully permissive to MERS-CoV infection was established in the DPP4 transgenic mice.
MERS-CoV replicated in the lung and brain, and viral RNA could also be detected in the heart, spleen, and intestine [18] . LLC-MK2 cells [19] . This therapeutic intervention was also evaluated in rhesus macaques. With the treatment 8hr after infection, the infected rhesus macaques showed virus replication reduction and clinical outcome improvement [20] .
However, the clinical experience from MERS patients showed that critically ill patients did not respond to this combination antiviral therapy [21] . on S1 protein of MERS-CoV have been shown to inhibit virus infection in vitro [14, [23] [24] [25] . However, these non-human antibodies were used with a limitation since adverse effects were induced when applied to human. . Ying et al. isolated three MAbs, m336, m337 and m338, targeting the RBD of MERS-CoV S1 protein with high affinity. Significantly, the m336 neutralized the MERS-CoV with exceptional potency, 50% neutralization at 0.07μg/ml [27] .
Development of effective vaccines against
MERS-CoV is also in the early stages. Using a reverse genetics system, a mutant virus lacking the structural E protein of MERS--CoV was engineered. This mutant virus was replication-competent, propagation-defective in cell cultures, and thus could be a promising vaccine candidate [28] . Recently, 
